CANNABIDEX

Welcome to the Brand page for “CANNABIDEX”, which is offered here for Pharmaceutical and veterinary preparations, herbs, herbal extracts, formulas containing herbal extracts, medicinal oils and pure extracts of medicinal plants and herbs, for use in the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; pharmaceutical and veterinary preparations for the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; herbs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes;.

Its status is currently believed to be active. Its class is unavailable. “CANNABIDEX” is believed to be currently owned by “GW Research Limited”.